18-month mortality | Â | 24-month mortality | ||
---|---|---|---|---|
Variables | VIP | Â | Variables | VIP |
MMP-7 < = 2 > 2 | 1.63 |  | P53% < 6 > = 6 | 1.81 |
P53% < 6 > = 6 | 1.50 | Ki 67 < 13 > = 13 | 1.67 | |
Ki 67 < 13 > = 13 | 1.40 | Vimentin < = 2 > 2 | 1.51 | |
COX < = 2 > 2 | 1.38 | CD34 < 30 > = 30 | 1.50 | |
Vimentin < = 2 > 2 | 1.34 | Regional lymph node (pN) < = N1 > N1 | 1.28 | |
CD34 < 30 > = 30 | 1.20 | Pathological tumor < T2 > = T2 | 1.23 | |
Pathological tumor < T2 > = T2 | 1.17 | HER-2 < = 1 > 1 | 1.20 | |
HER-2 < = 1 > 1 | 1.17 | COX < = 2 > 2 | 1.17 | |
Regional lymph node (pN) < = N1 > N1 | 1.06 | MMP-7 < = 2 > 2 | 1.02 |